ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

More Women Over 50 Report Having Had Mammograms.

July 28, 2000

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

ACS Announces New Awards for Nurses

October 30, 1987

SEER Program Challenged, Will Face Review

May 9, 1980